<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[Genzyme Corp. | Company News & Executive Profiles - GENZ | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/genzyme+corp..html?i=11]]></link>
	<description><![CDATA[Latest company news & analysis, recent events, stock quotes, earning call transcripts, with profiles and descriptions of top business executives for Genzyme Corp.]]></description>
	<s:counts start="0" returned="10" found="445" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Genzyme's Renagel / Renvela Franchise: Investors Would Be Wise to Reevaluate]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F175269-genzyme-s-renagel-renvela-franchise-investors-would-be-wise-to-reevaluate%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[This is a follow up to my previous post regarding the news that development of Genzyme&#8217;s GENZ follow-on product to its Renagel/Renvela franchise is being discontinued. The product, named GENZ-644470, is an advanced phosphate binder APB that was hoped to have demonstrated a superior clinical profile compared to predecessor Renvela....]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Wed, 25 Nov 2009 04:31:44 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/mark+mitchell.html"><![CDATA[Mark Mitchell]]></category>
		<category domain="http://resources.bnet.com/topic/genzyme+corp..html"><![CDATA[Genzyme Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/isis+pharmaceuticals+inc..html"><![CDATA[Isis Pharmaceuticals Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GENZ</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ISIS</category>
		<category domain="tickers">GENZ,ISIS</category>
	</item>
	<item>
		<title><![CDATA[Genzyme's Very Bad Year]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F174932-genzyme-s-very-bad-year%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[EP Vantage submits: Even before the FDA&#8217;s ominous announcement last week that it had found things that really should not be there in vials of Genzyme&#8217;s GENZ enzyme replacement products, the US biotech was certainly having a personal annus horribilis.          ...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Mon, 23 Nov 2009 01:32:12 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/ep+vantage.html"><![CDATA[EP Vantage]]></category>
		<category domain="http://resources.bnet.com/topic/genzyme+corp..html"><![CDATA[Genzyme Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/isis+pharmaceuticals+inc..html"><![CDATA[Isis Pharmaceuticals Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GENZ</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ISIS</category>
		<category domain="tickers">GENZ,ISIS</category>
	</item>
	<item>
		<title><![CDATA[Genzyme Kidney Drug Failed, Too...What Could Possibly Happen Next?]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10005452/genzyme-kidney-drug-failed-toowhat-could-possibly-happen-next/]]></link>
		<description><![CDATA[Just when you thought it couldn't get any worse for Genzyme, a disappointing Phase II/III trial means the end for the firm's next-generation kidney drug. What could possibly happen next? by Trista Morrison]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_bnet.gif" type="image/gif" />
		<pubDate>Sun, 22 Nov 2009 21:00:02 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/genzyme+corp..html"><![CDATA[Genzyme Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/kidney.html"><![CDATA[Kidney]]></category>
		<category domain="http://resources.bnet.com/topic/trista+morrison.html"><![CDATA[Trista Morrison]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GENZ</category>
		<category domain="tickers">GENZ</category>
	</item>
	<item>
		<title><![CDATA[Genzyme's Termeer Got $50M in Compensation Over Last 3 Years; Wife Got Trips to Asia on Corporate Jet]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10005414/genzymes-termeer-got-50m-in-compensation-over-last-3-years-wife-got-trips-to-asia-on-corporate-jet/]]></link>
		<description><![CDATA[Henri Termeer, the CEO of disaster-prone Genzyme GENZ, was given $50.8 million in compensation for the last three years, according to the company's filings with the SEC (see page 24). He earns about $14 million a year for running a company that has about $4 billion in sales. By contrast,...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_bnet.gif" type="image/gif" />
		<pubDate>Thu, 19 Nov 2009 15:32:08 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/compensation.html"><![CDATA[Compensation]]></category>
		<category domain="http://resources.bnet.com/topic/genzyme+corp..html"><![CDATA[Genzyme Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/benefits.html"><![CDATA[Benefits]]></category>
		<category domain="http://resources.bnet.com/topic/human+resources.html"><![CDATA[Human Resources]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GENZ</category>
		<category domain="tickers">GENZ</category>
	</item>
	<item>
		<title><![CDATA[Genzyme's Problems Continue with Discontinuation of Kidney Drug Development]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F174327-genzyme-s-problems-continue-with-discontinuation-of-kidney-drug-development%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Zacks.com submits:   Genzyme Corporation&#8217;s GENZ problems continue with the company recently announcing the discontinuation of the development of its kidney disease drug. Genzyme reported results on its advanced phosphate binder APB from a phase II/III study.  Although the candidate met its primary endpoint, results showed that it...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Thu, 19 Nov 2009 08:31:02 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/zacks.com.html"><![CDATA[Zacks.com]]></category>
		<category domain="http://resources.bnet.com/topic/genzyme+corp..html"><![CDATA[Genzyme Corp.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GENZ</category>
		<category domain="tickers">GENZ</category>
	</item>
	<item>
		<title><![CDATA[FDA Delays Genzyme's Lumizyme, Manufacturing Problems Blamed]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10005372/a-cure-for-genzymes-pompe-disease-treatment-ceo-termeers-ouster/]]></link>
		<description><![CDATA[Genzyme announced that the FDA is delaying final approval of the company's application to market Lumizyme alglucosidase alfa for the treatment of Pompe disease. Not unexpected, given FDA regulators had sent out a memo last Friday warning healthcare providers that enzyme replacement drugs made at the Allston Landing plant might...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_bnet.gif" type="image/gif" />
		<pubDate>Thu, 19 Nov 2009 07:56:16 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/genzyme+corp..html"><![CDATA[Genzyme Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/manufacturing.html"><![CDATA[Manufacturing]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/david+phillips.html"><![CDATA[David Phillips]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GENZ</category>
		<category domain="tickers">GENZ</category>
	</item>
	<item>
		<title><![CDATA[Genzyme: Contents Under Pressure]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/news-analysis/genzyme-contents-pressure/20849/]]></link>
		<description><![CDATA[Friday's announcement that bits of rubber and other detritus were found in vials of five different drugs manufactured at Genzyme's beleaguered Allston Landing plant was worthy of the satirical publication "The Onion"--except that it was true.The picture grew murkier over the weekend, with the arrival of another Form 483 missive...]]></description>
		<s:doctype><![CDATA[News items]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_bnet.gif" type="image/gif" />
		<pubDate>Wed, 18 Nov 2009 02:18:57 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/genzyme+corp..html"><![CDATA[Genzyme Corp.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GENZ</category>
		<category domain="tickers">GENZ</category>
	</item>
	<item>
		<title><![CDATA[Bring Me the Head of Genzyme CEO Henri Termeer!]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10005350/bring-me-the-head-of-genzyme-ceo-henri-termeer/]]></link>
		<description><![CDATA[How long will it be before Genzyme GENZ CEO Henri Termeer resigns? That question was asked openly at TheStreet.com, which named Termeer the worst Biotech CEO of 2009. A change of management at Genzyme is increasingly likely now that investor Carl Icahn has upped his stake in the company. by...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_bnet.gif" type="image/gif" />
		<pubDate>Tue, 17 Nov 2009 10:37:20 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/genzyme+corp..html"><![CDATA[Genzyme Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/ceo.html"><![CDATA[CEO]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/financial+accounting.html"><![CDATA[Financial Accounting]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GENZ</category>
		<category domain="tickers">GENZ</category>
	</item>
	<item>
		<title><![CDATA[FDA: Watch out for tainted Genzyme drugs]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/news-analysis/fda-watch-tainted-genzyme-drugs/20498/]]></link>
		<description><![CDATA[Genzyme just can't seem to catch a break. Vials of five of its meds for rare diseases may be tainted with bits of rubber, steel, or foreign fibers, the FDA said. And while the contamination doesn't seem to be widespread, it does raise more questions about quality control at the...]]></description>
		<s:doctype><![CDATA[News items]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_bnet.gif" type="image/gif" />
		<pubDate>Mon, 16 Nov 2009 08:36:13 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/genzyme+corp..html"><![CDATA[Genzyme Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/contamination.html"><![CDATA[Contamination]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GENZ</category>
		<category domain="tickers">GENZ</category>
	</item>
	<item>
		<title><![CDATA[Another Manufacturing Setback for Genzyme]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F173677-another-manufacturing-setback-for-genzyme%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Earlier this morning, Genzyme GENZ received another Complete Response Letter for its Pompe Disease drug Lumizyme. I had anticipated an Approval late last week. However, that was before the FDA and Genzyme announced last Friday that  foreign particles, e.g., stainless steel fragments, non-latex rubber and fiber-like material, were found...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Mon, 16 Nov 2009 02:37:17 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/mark+mitchell.html"><![CDATA[Mark Mitchell]]></category>
		<category domain="http://resources.bnet.com/topic/genzyme+corp..html"><![CDATA[Genzyme Corp.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GENZ</category>
		<category domain="tickers">GENZ</category>
	</item>
</channel>
</rss>
